CIS Clinical Trial Market Analyzed in New PMR Research Report Published at

01 Feb 2012 • by Natalie Aster
CIS Clinical Trial Market Analyzed in New PMR Research Report Published at

LONDON – Which country should be chosen to conduct a clinical trial and which should be avoided? What are the conditions, pros and cons of conducting clinical trials in Russia, Ukraine, Belarus and Georgia? Which are the largest sponsors in the region, what kind of drugs are they currently investigating and which phases of clinical trials do they conduct? What are the largest CROs in the region? In which countries are delays expected during the registration of a clinical trial? What is the average time to register a clinical trial in particular countries? What are the most important legal regulations? Answers to all these questions and many more can be found in the research report.

New market research report “Clinical Trials in CIS Countries 2012” developed by PMR has been recently published by Market Publishers Ltd.

Report Details:

Clinical Trials in CIS Countries 2012
Published: January 2012
Pages: 121
Price: US$ 2.800,00

The report focuses on clinical trial operating conditions in the following CIS countries – Russia, Ukraine, Belarus and Georgia, offering statistical data and analysis on the present-day market size with forecasts through 2014.

Report Highlights:

  • market current and anticipated situation;
  • market growth opportunities and obstacles;
  • average registration time for clinical trials;
  • major characteristics and market standing of top companies conducting clinical trials.

The study also includes a comparative analysis of conditions governing the performance of clinical trials in the CIS countries analyzed. The operations of major pharmaceutical corporations active in CIS are then presented, with special attention given to the number of trials, location, and therapeutic areas.

More new market research reports by the publisher can be found at PMR page.


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970